Risersect 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended starting dose in patients taking levodopa is 0.5 mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1 mg once daily. This medicine may be taken with or without food.

This drug should not be used by individuals who are hypersensitive to the active ingredient or other components. This medicine should not be taken by those who are currently taking or have recently discontinued other MAO inhibitors or natural medicines within the last two weeks. Especially, patients who are currently taking or have recently discontinued certain medications such as pethidine, tramadol, or dextromethorphan should also avoid this drug. Administration is prohibited for patients with moderate to severe liver impairment. Various side effects, such as flu-like symptoms, skin cancer, leukopenia, allergies, headaches, dizziness, nausea, and insomnia, may occur when taking this drug, so caution is necessary. This drug is used for the treatment of Parkinson's disease, and may cause movement disorders or psychiatric side effects, requiring regular monitoring. As drowsiness or sudden sleep attacks may occur during treatment, caution should be exercised when driving or operating dangerous machinery. Since there are many interactions with other drugs, it is especially important to take care not to combine this drug with antidepressants, sympathomimetics, or certain analgesics. If pregnant or breastfeeding, safety has not been established for this drug, and it should only be used after consulting a professional. This drug should not be used in children under 18 years of age, as safety and efficacy have not been established. In case of overdose, serious side effects may occur, and immediate medical assistance should be sought, as there is no specific antidote, requiring treatment according to symptoms. This drug should be stored in a cool place out of reach of children, and it is recommended not to transfer it to another container.

• Influenza
• skin cancer
• leukopenia
• allergy
• appetite loss
• depression
• hallucination
• headache
• cerebrovascular accident
• conjunctivitis

This medicine must be stored in a tightly closed container to protect it from air and moisture. Additionally, it is important to store the drug at a cool temperature between 1 degree and 25 degrees Celsius to maintain its effectiveness.

Appearance

Flat round tablets with corners, white or almost white

Package unit

30 tablets/bottle